AArtificial intelligence Read More Seasoned Healthcare Executive Raises $52 Million For An AI Health StartupNovember 29, 2025 Michelle Carnahan has spent the better part of the last three decades working in healthcare at companies like…
HHealthcare Read More This Healthcare Company Just Touched $1 Trillion in Market Cap. Should You Invest $1,000?November 27, 2025 Eli Lilly has a dominant share of the huge and expanding GLP-1 drug market. Its GLP-1 drugs will…
HHealthcare Read More Why big pharma is teaming up with AI giants to speed up drug discovery and make work easier for health care workersNovember 20, 2025 AI chip maker Nvidia’s fresh partnerships with Eli Lilly and Johnson & Johnson point to a broader trend…
HHealthcare Read More Why big pharma is teaming up with AI giants to speed up drug discovery and make work easier for health care workersNovember 20, 2025 AI chip maker Nvidia’s fresh partnerships with Eli Lilly and Johnson & Johnson point to a broader trend…
MMedication Read More Novo chops Wegovy prices, but doctors still see affordability challenges for patientsNovember 17, 2025 Novo Nordisk is chopping prices again for its popular obesity treatment Wegovy, but doctors say the expense will…
HHealthcare Read More Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare Giants’ Stocks?November 17, 2025 Don’t look now, but the costs of America’s beloved weight loss drugs are about to come down. Way…
HHealthcare Read More Who’s Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?November 12, 2025 Eli Lilly’s GLP-1 drug is now the world’s best-selling drug. Novo Nordisk is struggling with declining market share.…
HHealthcare Read More Three Healthcare Buys That Wall Street LovesNovember 11, 2025 Healthcare stocks are hot right now. Several factors are driving them higher, including innovations in areas like heart…
HHealthcare Read More 3 Fantastic Growth Opportunities for Eli Lilly That Go Beyond GLP-1 DrugsNovember 10, 2025 Eli Lilly has been investing in radiopharmaceuticals, which can help revolutionize cancer care in the future. Its early…
MMedication Read More Mounjaro mounts to top spot in Indian drug market; Oct sales touch ₹100 cr, ETPharmaNovember 8, 2025 New Delhi: Maintaining its growth momentum for the seventh straight month, Eli Lilly’s type-2 diabetes and weight-loss drug…
MMedication Read More Weight loss gets cheaper: New White House deal slashes prices of Ozempic and Wegovy |November 6, 2025 The cost of some of the most widely used weight loss medications in the United States is set…
MMedication Read More Weight-Loss Drug Zepbound Gets Walmart D2C PricingNovember 5, 2025 Consumers will soon be able to pick up single-dose vials of the weight loss drug Zepbound at Walmart…